INMB (STOCKS)
INmune Bio Inc. Common stock
$2.060000
+0.020000 (+0.98%)
Prev close: $2.040000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David J. Moss, MBA
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $57.38M
- Employees
- 13
- P/E (TTM)
- -3.00
- P/B (TTM)
- 2.66
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $1.78M |
| Operating Expenses | $20.20M |
| Operating Income/Loss | -$20.20M |
| Income/Loss From Continuing Operations After Tax | $73.45M |
| Income/Loss From Continuing Operations Before Tax | $32.73M |
| Net Income/Loss | -$18.42M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$18.42M |
| Net Income/Loss Available To Common Stockholders, Basic | -$18.42M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.67 |
| Diluted Earnings Per Share | -$0.67 |
| Basic Average Shares | 80,504,955 |
| Diluted Average Shares | 80,504,955 |
| Assets | $26.85M |
| Current Assets | $23.80M |
| Noncurrent Assets | $3.05M |
| Fixed Assets | $1.26M |
| Other Non-current Assets | $1.78M |
| Liabilities | $6.48M |
| Current Liabilities | $5.89M |
| Noncurrent Liabilities | $593.00K |
| Equity | $20.36M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $20.36M |
| Liabilities And Equity | $26.85M |
| Net Cash Flow From Operating Activities | -$14.96M |
| Net Cash Flow From Operating Activities, Continuing | -$14.96M |
| Net Cash Flow From Investing Activities | -$4.60M |
| Net Cash Flow From Investing Activities, Continuing | -$4.75M |
| Net Cash Flow From Financing Activities | $816.00K |
| Net Cash Flow From Financing Activities, Continuing | $816.00K |
| Exchange Gains/Losses | -$52.00K |
| Net Cash Flow | -$18.63M |
| Net Cash Flow, Continuing | -$18.58M |
| Comprehensive Income/Loss | -$18.49M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$18.48M |
| Other Comprehensive Income/Loss | -$13.08M |